HMOX1 and Alzheimer disease: Another study reports no changes in the serum level of HO-1 in a big cohort of AD patients in comparison to normal elderly control samples, and also reports the increased level of serum HO-1 in Parkinson patients, underlining the existence of different mechanisms involved in the peripheral response to oxidative stress in the two diseases [134].